Gerresheimer reported preliminary third-quarter 2026 revenue of EUR 605m, up 8% year on year. Adjusted EBITDA was EUR 103m against EUR 106m, and the margin fell to 17.1% from 19.0%. After completing the Centor sale in October, Gerresheimer now expects its Primary Packaging Plastics sale to close in the first quarter of 2027. It targets nearly EUR 700m of debt repayment by year-end and expects leverage of about 3x adjusted EBITDA after both disposals. Full-year guidance was maintained.
Why this mattersDisposal proceeds are funding close to EUR 700m of debt repayment, cutting leverage to about 3x, while margins slip slightly despite 8% revenue growth.
- Q3 2026 revenue was EUR 605m, up 8% year on year, with growth in all three segments.
- Q3 2026 adjusted EBITDA was EUR 103m, a 17.1% margin, down EUR 3m year on year.
- Nine-month 2026 revenue was about EUR 1.7bn with adjusted EBITDA of EUR 272m.
- Centor sale completed in October 2026; the Primary Packaging Plastics sale is now expected to close in the first quarter of 2027.
- Nearly EUR 700m of debt is targeted for repayment by year-end; leverage is expected to fall to about 3x adjusted EBITDA after both disposals.
- Full-year guidance maintained at EUR 2.3bn to EUR 2.35bn revenue, 17% to 18% organic adjusted EBITDA margin, and negative EUR 50m to EUR 100m free cash flow before M&A.
- Gross debt stood at just under EUR 2.3bn before the Centor and Primary Packaging Plastics disposals, with a path to below EUR 900m after both close.
- Gerresheimer closed its Chicago Heights, Illinois moulded-glass plant in September 2026.
The European Commission has cleared Apax Partners' purchase of Gerresheimer's Primary Packaging Plastics unit, a business valued with Centor at about USD 1.68bn (EUR 1.5bn) enterprise value under the agreement signed in late July. The two businesses ran 16 plants in nine countries, employed around 2,400 people and generated about USD 639m (EUR 570m) of revenue in 2025. The Commission found no overlap in the same or vertically related markets and reviewed the case under its simplified procedure.
Why this mattersClearance moves a EUR 1.5bn pharmaceutical and cosmetics primary-packaging platform into private equity hands and funds Gerresheimer's shift to drug delivery and injectables.
- European Commission cleared Apax Partners' acquisition of sole control of Gerresheimer's Primary Packaging Plastics unit on 8 October 2026 under the EU Merger Regulation
- The late-July agreement, which also included Centor, values the businesses at about USD 1.68bn (EUR 1.5bn) on an enterprise value basis
- The two businesses operated 16 plants across nine countries, employed around 2,400 people and generated about USD 639m (EUR 570m) of revenue in 2025
- The unit makes primary plastic packaging, mainly for pharmaceutical, personal care and cosmetics customers
- The Commission found the parties are not active in the same or vertically related markets; case number M.12602, simplified procedure
- Gerresheimer is divesting to reduce debt and focus on drug delivery systems, medical devices and primary packaging for injectable medicines
Gerresheimer completed the sale of its Centor business on 1 October 2026 at an enterprise value of EUR 1.50bn (USD 1.68bn), as part of a reorganisation of its portfolio. Adjusted EBITDA rose to EUR 102m in the second quarter of 2026 from EUR 67m in the first, on revenue of EUR 578m, below the EUR 614m of the prior-year quarter. A half-year report is due in November 2026 and a third-quarter statement in December.
Why this mattersCompletion closes a EUR 1.50bn step in Gerresheimer's portfolio reshaping, while second-quarter revenue still ran 6% below the prior year despite the EBITDA recovery.
- Centor sale completed on 1 October 2026 at an enterprise value of EUR 1.50bn (USD 1.68bn)
- Q2 2026 adjusted EBITDA rose to EUR 102m from EUR 67m in Q1
- Q2 2026 revenue was EUR 578m, up from EUR 523m in Q1 but below EUR 614m a year earlier
- Half-year financial report due in November 2026, third-quarter statement due in December 2026
Gerresheimer completed the sale of its US closures subsidiary Centor to funds advised by Apax Partners on 1 October 2026, about two months after signing on 29 July 2026. Centor accounts for roughly half of the combined enterprise value of about EUR 1.5bn (USD 1.7bn) agreed for Centor and the group's global Primary Packaging Plastics business. The proceeds go to debt reduction; the Primary Packaging Plastics sale is still expected to close in the first half of 2027, followed by a group refinancing.
Why this mattersThe closures exit funds deleveraging and leaves Gerresheimer concentrated on primary pharmaceutical packaging and drug-delivery systems, with one disposal still to run.
- Centor sale completed on 1 October 2026, about two months after the agreement signed on 29 July 2026
- Buyer is funds advised by Apax Partners
- Centor represents about half of the combined enterprise value of roughly EUR 1.5bn (USD 1.7bn) agreed for Centor and Primary Packaging Plastics
- Proceeds are earmarked for debt reduction, according to CFO Wolf Lehmann
- Primary Packaging Plastics disposal is expected to close in the first half of 2027, with a comprehensive group refinancing prepared with lenders afterwards
- Gerresheimer reports Q3 2026 results on 31 October 2026